Myocardial infarction was the predominant clinical diagnosis and all patients were NYHA class I. Pharmacologic treatment commonly included antiplatelets, statins, beta-blockers, ACE inhibitors, and hypoglycemic agents. This evidence concerns the gene ACE and myocardial infarction.